Komori
M&A and Subsidiary Changes6645OMRON CorporationElectrical Equipment and Precision Instruments

Notice Regarding the Commencement of a Tender Offer for the Shares, etc. (Securities Code: 7317) of Matsuya R&D Co., Ltd. by the Company's Subsidiary, OMRON HEALTHCARE Co., Ltd.

OMRON HEALTHCARE will commence the previously announced tender offer for Matsuya R&D on 19 May 2026, following completion of the procedures required under Taiwan and Vietnam competition laws and satisfaction of the other conditions precedent. The tender offer price and terms remain unchanged from those announced on 15 December 2025.

Worth reading
91Important
Scored from 4 of 5 sections
Direction
Improvement
Direction inferred from the company’s description.
Scale
1110
¥ per share
Wording
Definitive
How definitive the wording is.

This transaction

This tender offer
CounterpartyShareholders and holders of stock acquisition rights of Matsuya R&D Co., Ltd., Goto Hidetaka (後藤秀隆氏), Goto Tomohiro (後藤倫啓氏), Goto Masahiro (後藤匡啓氏), ゴトウホールディング株式会社
Disclosing companyOMRON Corporation
Matsuya R&D Co., Ltd.Voting rights ownership percentageNumber of shares acquired The tender offeror intends to acquire all shares and stock acquisition rights of the target company, excluding shares held by the tender offeror, treasury shares and other excluded securities. The shares subject to tender agreements total 11,080,000 shares.

The voting-rights ratio is the share of the votes exercisable at a shareholders’ meeting that will be held after this transaction.

TimelineThe spacing between the points is proportional to the actual number of days.
Target company

Development, manufacture and sale of automated sewing machines, and manufacture and sale of various sewn products using proprietary automated sewing machines

Location Ono, Fukui Prefecture
Consideration and expenses
Acquisition price¥1,110 per share (¥717,600 per stock acquisition right)
Type of ConsiderationCash
Tender offer price¥1,110 per common share and ¥717,600 per stock acquisition right
Minimum number of shares to be purchased11,230,300 shares
Tender offer periodFrom 19 May 2026 through 15 June 2026 (20 business days). If the target company requests an extension, through 29 June 2026 (30 business days)
Procedures and assumptions
Valuation methodologyMarket price method, comparable companies analysis and DCF method (tender offeror); average market price method and DCF method (target company)
Independent valuation institutionMizuho Securities Co., Ltd.; Nomura Securities Co., Ltd.
Special CommitteeEstablished. The 3 members are Nishikimi Mitsuhiro (錦見光弘氏), Sasaki Yutaka (佐々木豊氏) and Uruma Keigo (漆間圭吾氏), comprising 2 independent outside Audit & Supervisory Board members and 1 independent outside director.
Conditions Precedent to ExecutionApproval and recommendation to tender by the target company's board of directors; a favorable opinion from the Special Committee; completion of procedures required under foreign competition laws; no undisclosed material facts or other matters; no petition or other action prohibiting or restricting commencement of the tender offer; no material adverse effect; and continued validity of the tender agreement, among other conditions.
Management structure after acquisitionThe tender offeror expects to respect the target company's corporate culture and management independence and, for the time being, continue its existing management policies and structure. Coordination, including the secondment of officers from the group, is planned, but no decisions have been made. The target company is expected to become a wholly owned subsidiary and be delisted.
This transaction
ItemDetails
Transaction nameThis tender offer
Counterparty nameShareholders and holders of stock acquisition rights of Matsuya R&D Co., Ltd., Goto Hidetaka (後藤秀隆氏), Goto Tomohiro (後藤倫啓氏), Goto Masahiro (後藤匡啓氏), ゴトウホールディング株式会社
Name of the Subject CompanyMatsuya R&D Co., Ltd.
Business Description of the Subject CompanyDevelopment, manufacture and sale of automated sewing machines, and manufacture and sale of various sewn products using proprietary automated sewing machines
Location of the Subject CompanyOno, Fukui Prefecture
Acquisition price¥1,110 per share (¥717,600 per stock acquisition right)
Type of ConsiderationCash
Tender offer price¥1,110 per common share and ¥717,600 per stock acquisition right
Minimum number of shares to be purchased11,230,300 shares
Tender offer periodFrom 19 May 2026 through 15 June 2026 (20 business days). If the target company requests an extension, through 29 June 2026 (30 business days)
Number of shares acquiredThe tender offeror intends to acquire all shares and stock acquisition rights of the target company, excluding shares held by the tender offeror, treasury shares and other excluded securities. The shares subject to tender agreements total 11,080,000 shares.
Voting rights ownership percentageBefore 14.64% → after 66.57% (assuming the minimum number of shares to be purchased)
Date of board resolution18 May 2026
Contract Date15 December 2025 (tender agreement)
Execution Date / Effective Date19 May 2026 (tender offer commencement date). A squeeze-out is planned after the tender offer.
Valuation methodologyMarket price method, comparable companies analysis and DCF method (tender offeror); average market price method and DCF method (target company)
Independent valuation institutionMizuho Securities Co., Ltd.; Nomura Securities Co., Ltd.
Special CommitteeEstablished. The 3 members are Nishikimi Mitsuhiro (錦見光弘氏), Sasaki Yutaka (佐々木豊氏) and Uruma Keigo (漆間圭吾氏), comprising 2 independent outside Audit & Supervisory Board members and 1 independent outside director.
Conditions Precedent to ExecutionApproval and recommendation to tender by the target company's board of directors; a favorable opinion from the Special Committee; completion of procedures required under foreign competition laws; no undisclosed material facts or other matters; no petition or other action prohibiting or restricting commencement of the tender offer; no material adverse effect; and continued validity of the tender agreement, among other conditions.
Management structure after acquisitionThe tender offeror expects to respect the target company's corporate culture and management independence and, for the time being, continue its existing management policies and structure. Coordination, including the secondment of officers from the group, is planned, but no decisions have been made. The target company is expected to become a wholly owned subsidiary and be delisted.
Items this document does not state (12)
Capital Stock of the Subject CompanyDate of Establishment of the Subject CompanyNet Sales of the Subject CompanyOperating Profit of the Subject CompanyNet Income of the Subject CompanyNet Assets of the Subject CompanyExpenses other than the acquisition priceMerger ratio/share exchange ratioFunding arrangementsGoodwill amountAmount of extraordinary income (loss)Impact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The procedures required under the competition laws of Taiwan and Vietnam have been completed, and the conditions precedent to the tender offer have been satisfied, including the target company's approval and recommendation to tender, the Special Committee's favorable opinion, and confirmation that no material adverse effect has occurred.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Commencement of a Tender Offer for the Shares, etc. (Securities Code: 7317) of Matsuya R&D Co., Ltd. by the Company's Subsidiary, OMRON HEALTHCARE Co., Ltd. | OMRON Corporation (6645) timely disclosure | Komori